HomeinvestmentGSK plans $30 billion US investment as pharma tariff threat looms investment GSK plans $30 billion US investment as pharma tariff threat looms By web-interns@dakdan.com September 17, 2025 0 28 Share XLinkedinReddIt The company said its new facilities will Share XLinkedinReddIt Previous articleUK Looks to US to Adopt More Crypto-Friendly ApproachNext articleWith Trump in the U.K., GSK touts $30 billion investment in U.S. over 5 years web-interns@dakdan.com RELATED ARTICLES investment Paraguay offers direct permanent residency with $150,000 investment April 21, 2026 investment Polymarket in Talks to Raise $400M at $15B Valuation: Report April 21, 2026 investment Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride April 21, 2026 - Advertisment - Most Popular Indian insurer HDFC Life’s new business growth slows April 28, 2026 U.S. Tax Court Rules Life Insurance Policy Termination Results in Taxable Income for Business Owner April 28, 2026 India’s SBI Life confident about handling potential tightening of key sales channel April 28, 2026 Courier Health raises $50M to fix broken patient journeys with AI in biopharma April 28, 2026 Load more Recent Comments